ISIN | LU1585228882 |
---|---|
Valorennummer | |
Bloomberg Global ID | |
Fondsname | Bellevue Emerging Markets Healthcare I EUR |
Fondsanbieter |
Bellevue Asset Management AG
Zürich, Schweiz Telefon: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fondsanbieter | Bellevue Asset Management AG |
Vertreter in der Schweiz |
Waystone Fund Services (Switzerland) SA Lausanne Telefon: 0041213111781 |
Distributor(en) |
Bank am Bellevue AG Küsnacht Telefon: +41 44 267 67 67 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. |
Besonderheiten |
Aktueller Preis * | 124.52 EUR | 26.11.2024 |
---|---|---|
Vorheriger Preis * | 125.00 EUR | 25.11.2024 |
52 Wochen Hoch * | 139.11 EUR | 04.10.2024 |
52 Wochen Tief * | 114.14 EUR | 31.05.2024 |
NAV * | 124.52 EUR | 26.11.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 75'219'662 | |
Anteilsklassevermögen *** | ||
Trading Information SIX |
YTD-Performance | -7.59% |
29.12.2023 - 26.11.2024
29.12.2023 26.11.2024 |
---|---|---|
YTD-Performance (in CHF) | -7.47% |
29.12.2023 - 26.11.2024
29.12.2023 26.11.2024 |
1 Monat | -5.49% |
28.10.2024 - 26.11.2024
28.10.2024 26.11.2024 |
3 Monate | +0.12% |
26.08.2024 - 26.11.2024
26.08.2024 26.11.2024 |
6 Monate | +5.85% |
27.05.2024 - 26.11.2024
27.05.2024 26.11.2024 |
1 Jahr | -9.31% |
27.11.2023 - 26.11.2024
27.11.2023 26.11.2024 |
2 Jahre | -12.35% |
28.11.2022 - 26.11.2024
28.11.2022 26.11.2024 |
3 Jahre | -36.02% |
26.11.2021 - 26.11.2024
26.11.2021 26.11.2024 |
5 Jahre | -44.81% |
15.06.2021 - 26.11.2024
15.06.2021 26.11.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Sun Pharmaceuticals Industries Ltd | 6.74% | |
---|---|---|
Akeso Inc Ordinary Shares | 6.18% | |
Celltrion Inc | 5.90% | |
Samsung BioLogics Co Ltd | 4.82% | |
Innovent Biologics Inc | 4.16% | |
SK Biopharmaceuticals Co Ltd Ordinary Shares | 4.14% | |
Bumrungrad Hospital PCL | 4.01% | |
BeiGene Ltd ADR | 3.87% | |
Hansoh Pharmaceutical Group Co Ltd | 3.87% | |
Apollo Hospitals Enterprise Ltd | 3.73% | |
Letzte Daten-Aktualisierung | 31.10.2024 |
TER | 1.58% |
---|---|
Datum TER | 29.01.2021 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 1.54% |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |